IDH2 and angioimmunoblastic T-cell lymphoma: Some studies have provided another evidence for this: the R172 mutation in IDH2 has a greater ability to produce 2-HG in lymphoid cells and can damage the development of lymphoid cells, which may explain the advantage of this mutation in AITL (71).